BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22627012)

  • 1. Severe hypomagnesemia and hypoparathyroidism induced by omeprazole.
    Rodríguez Ortega P; Rebollo Pérez I; Laínez López M; Roldán Mayorga E; Hernández Lavado R; Creagh Cerquera R
    Endocrinol Nutr; 2013 Mar; 60(3):156-7. PubMed ID: 22627012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypomagnesemia induced by proton pump inhibitors, diarrhea, and lactose intolerance].
    Cano Megías M; Alvarez Santirso R; Iglesias Lozano P; Carrasco De La Fuente M; Pérez López G
    Endocrinol Nutr; 2011 Dec; 58(10):550-4. PubMed ID: 21764396
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults.
    Pastorino A; Greppi F; Bergamo D; Versino E; Bo M; Pezzilli MS; Furno E; Rrodhe S; Isaia G
    J Am Geriatr Soc; 2015 Jan; 63(1):179-80. PubMed ID: 25597570
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In brief: PPI's and hypomagnesemia.
    Med Lett Drugs Ther; 2011 Apr; 53(1361):25. PubMed ID: 21464802
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drugs affecting serum magnesium concentration].
    Kawamura Y
    Clin Calcium; 2012 Aug; 22(8):1211-6. PubMed ID: 22846357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].
    Piezzi V; Kullak-Ublick GA; Glisenti P
    Internist (Berl); 2014 Feb; 55(2):199-205. PubMed ID: 24419536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructural intestinal mucosa change after prolonged inhibition of gastric acid secretion by omeprazole in male rats.
    Chamniansawat S; Kampuang N; Suksridechacin N; Thongon N
    Anat Sci Int; 2021 Jan; 96(1):142-156. PubMed ID: 32931001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated hypomagnesemia in a patient treated with capecitabine.
    Rajapakse S; Rodrigo C; Rajapakse AC
    J Oncol Pharm Pract; 2013 Sep; 19(3):254-6. PubMed ID: 22948887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
    Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
    PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(5):322-6. PubMed ID: 22745572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review: UPDATE on magnesium metabolism].
    Fatuzzo P; Zanoli L; Scollo V; Portale G; Gaudio A; Pani A; Granata A
    G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypomagnesemia and electrolyte disturbances induced by proton pump inhibitors.
    Turnock M; Pagnoux C; Shore K
    J Dig Dis; 2014 Aug; 15(8):459-62. PubMed ID: 24798177
    [No Abstract]   [Full Text] [Related]  

  • 17. [Emergent adverse effects of proton pump inhibitors].
    Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
    Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and causes of hypomagnesemia.
    Agus ZS
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):301-7. PubMed ID: 27219040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
    Swaminathan K
    Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.